Alendronate for fracture prevention in postmenopause

American Family Physician

Volumn 78, Issue 5, 2008, Pages 579-581

  Holder, Kathryn K ^a   Kerley, Sara Shelton ^a  

^a DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; PLACEBO; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; CALCIUM INTAKE; CASE REPORT; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DATA BASE; DATA COLLECTION METHOD; DIGESTIVE SYSTEM INJURY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; EMBASE; FEMALE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; JAW OSTEONECROSIS; MEDLINE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY PREVENTION; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION; WRIST FRACTURE; MIDDLE AGED; PATHOLOGIC FRACTURE; REVIEW;

ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 53049086902     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008;(1):CD001155. (Pubitemid 351807494)
2. Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada [published corrections appear in CMAJ. 2003;168(4):400, CMAJ. 2003;168(6):676, and CMAJ. 2003;168(5):544]. CMAJ. 2002;167(10 Suppl):S1-S34. (Pubitemid 35365303)
3. American College of Obstetricians and Gynecologists, Women's Health Care Physicians. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 50, January 2003. Obstet Gynecol. 2004;103(1):203-216.
4. National Osteoporosis Foundation, American Academy of Orthopaedic Surgeons. Physician's Guide to Prevention and Treatment of Osteoporosis. 2nd ed. Washington, DC: National Osteoporosis Foundation, 2003.
5. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws [published correction appears in Ann Intern Med. 2006;145(3):235]. Ann Intern Med. 2006;144(10):753-761.
6. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336(7638):262-266. (Pubitemid 351251627)